Clinical Diagnostics Insider

Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies

AI in Health Care: Balancing Benefits and Barriers

By Michael Schubert, PhD | Oct 30, 2024 | 1 min read

AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding

By Ron Shinkman | Oct 29, 2024 | 1 min read

How three companies are addressing screening challenges with tests that help improve chances of early detection

By Michael Schubert, PhD | Oct 28, 2024 | 1 min read

Computational biology expert Keaun Amani shares his advice and insights on AI and machine learning tools for the clinical lab

By Michael Schubert, PhD | Jun 21, 2024 | 1 min read

What lab tests currently inform mental health care—and how might the testing landscape change as our understanding and technologies evolve?

By Oscelle Boye, MBiomed | Jun 21, 2024 | 1 min read

Workplace bullying is a serious concern in the clinical lab. How can it be addressed?

By Rachel Muenz | May 30, 2024 | 1 min read

Andreas Jeromin, PhD, chief scientific officer at ALZPath, discusses the current landscape of blood-based AD tests and their future.

By Rachel Muenz | May 30, 2024 | 1 min read

Alison Green, PhD, head of laboratory sciences at Scottish Brain Sciences, discusses recent developments in AD blood tests

By Michael Schubert, PhD | May 27, 2024 | 1 min read

A new capillary blood collection system, the BD MiniDraw™, can improve the testing experience for both labs and patients

By Oscelle Boye, MBiomed | May 27, 2024 | 1 min read

Examining what led to record low BB/TM ABPath certification examination pass rates in 2022

By Ron Shinkman | May 27, 2024 | 1 min read

Publishing peer-reviewed studies to tout the economic benefits of medical devices is fairly commonplace, but rare for a laboratory company

By Michael Schubert, PhD | May 24, 2024 | 1 min read

Multicancer early detection tests—and their promise of comprehensive, minimally invasive screening—are catching the eye of labs and lawmakers

By Ron Shinkman | Apr 26, 2024 | 1 min read

Though not expected to drastically change the program, new component gives device makers another way to strengthen their submissions

By Michael Schubert, PhD | Apr 26, 2024 | 1 min read

The laboratory’s role in reaching underserved patient populations: an interview with Richard Levenson, Keisuke Nakagawa, and Michele Mitchell